Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M89,592Revenue (TTM) $M51,309Net Margin (%)9.8Altman Z-Score1.9
Enterprise Value $M111,143EPS (TTM) $6.1Operating Margin %11.5Piotroski F-Score7
P/E(ttm)17.9Beneish M-Score-2.6Pre-tax Margin (%)12.7Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %5.8Quick Ratio1.0Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %7.6Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow16.2y-y EBITDA Growth Rate %19.6ROA % (ttm)6.0Higher Current Ratio y-yY
Dividend Yield %2.6PEG2.4ROE % (ttm)19.5Less Shares Outstanding y-yY
Payout Ratio %47.0Shares Outstanding M827ROIC % (ttm)9.9Gross Margin Increase y-yY

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAYRYKen Fisher 2016-06-30 Add0.02%$95.22 - $124.7
($108.57)
$ 108.34-0%Add 1.58%4,909,612
BAYRYKen Fisher 2016-03-31 Add0.03%$103.65 - $124.84
($111.18)
$ 108.34-3%Add 2.63%4,833,445
BAYRYKen Fisher 2015-12-31 Reduce$122.36 - $135.71
($128.61)
$ 108.34-16%Reduce -0.07%4,709,574
BAYRYKen Fisher 2015-09-30 Add0.03%$127.13 - $151.47
($139.59)
$ 108.34-22%Add 2.22%4,712,759
BAYRYKen Fisher 2015-06-30 Add0.59%$139.35 - $155
($147.22)
$ 108.34-26%Add 83.74%4,610,296
BAYRYKen Fisher 2015-03-31 Add$130.2 - $155.97
($144.95)
$ 108.34-25%Add 0.63%2,509,075
BAYRYKen Fisher 2014-06-30 Add0.6%$126.84 - $144.81
($138.38)
$ 108.34-22%Add 750.48%2,302,369
BAYRYKen Fisher 2014-03-31 Add0.06%$128.3 - $142.7
($135.49)
$ 108.34-20%Add 217.05%270,713
BAYRYKen Fisher 2013-06-30 Add0.01%$101 - $112.75
($106.88)
$ 108.341%Add 34.62%84,456
BAYRYVanguard Health Care Fund 2012-09-30 Reduce-0.03%$68.01 - $88.62
($77.6)
$ 108.3440%Reduce -3.71%2,594,656
BAYRYKen Fisher 2012-09-30 Buy 0.02%$68.01 - $88.62
($77.14)
$ 108.3440%New holding72,838
BAYRYKen Fisher 2012-03-31 Sold Out -0.01%$0.04 - $75.15
($59.98)
$ 108.3481%Sold Out0
BAYRYKen Fisher 2011-09-30 Add$49.73 - $84.17
($66.88)
$ 108.3462%Add 24.27%46,440
BAYRYKeeley Asset Management Corp 2009-06-30 Sold Out -0.01%$47.66 - $59.35
($52.77)
$ 108.34105%Sold Out0
BAYRYKen Fisher 2009-06-30 Sold Out $47.66 - $59.35
($52.77)
$ 108.34105%Sold Out0
BAYRYKeeley Asset Management Corp 2009-03-31 Buy 0.01%$43.75 - $59.4
($52.7)
$ 108.34106%New holding6,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAYRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BAYRY:

    News about BAYRY:

    Articles On GuruFocus.com
    Causeway International Value Fund May Performance Review Jul 08 2016 
    Ken Fisher Cuts His Stake in Royal Bank, Buys Roche Holding Oct 12 2015 
    Ken Fisher's most weighted buys in Q2 2015 Jul 28 2015 
    UnitedHealth Group Reports Strong Second Quarter Earnings Results Jul 21 2015 
    Bayer AG Wins Approval On Existing Antibiotic For Plague Treatment May 12 2015 
    Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
    DuPont Eyeing Acquisition To Leverage Its Market Spread Apr 24 2015 
    Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 

    More From Other Websites
    4:36 am Bayer reports new data for Xarelto, reaffirming positive benefit-risk profile in everyday... Aug 29 2016
    Not intended for U.S. and UK Media - ESC Congress 2016: -- Real-World Data from Multiple Countries... Aug 29 2016
    Company News for August 24, 2016 Aug 24 2016
    Monsanto Shares Climb on Report of Constructive Bayer AG Takeover Talks Aug 23 2016
    Bayer, Monsanto Talks Said to Inch Closer to a Deal Aug 23 2016
    Negotiations between Bayer, Monsanto move forward: Report Aug 23 2016
    Bayer Must Overcome Incredible Hulk, Regulators in Monsanto Bid Aug 23 2016
    Bayer, Monsanto Must Overcome Incredible Hulk, Regulators Aug 23 2016
    Monsanto (MON) Stock Climbs, Reportedly Nearing Deal with Bayer Aug 23 2016
    Bayer, Monsanto Said to Move Closer to Deal as Talks Progress Aug 23 2016
    Bayer, Monsanto Said to Move Closer to Deal as Talks Advance Aug 23 2016
    Not intended for U.S. and UK Media -- New Real-World Evidence on Venous and Arterial Blood Clot... Aug 22 2016
    Monsanto gives Bayer limited access to its books: sources Aug 17 2016
    Monsanto gives Bayer limited access to its books -sources Aug 17 2016
    Monsanto (MON) Stock Down, Giving Bayer Limited Access to Books Aug 17 2016
    Monsanto gives Bayer limited access to its books - sources Aug 17 2016
    Monsanto gives Bayer limited access to information -sources Aug 17 2016
    [$$] Pesticides affect 'far more species' of bees, says study Aug 16 2016
    Bayer could launch hostile bid for Monsanto: report Aug 16 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)